101 related articles for article (PubMed ID: 27613604)
1. CD133 Stimulates Cell Proliferation via the Upregulation of Amphiregulin in Melanoma.
Simbulan-Rosenthal CM; Islam N; Haribabu Y; Alobaidi R; Shalamzari A; Graham G; Kuo LW; Sykora P; Rosenthal DS
Cells; 2024 May; 13(9):. PubMed ID: 38727313
[TBL] [Abstract][Full Text] [Related]
2. A cellular hierarchy in melanoma uncouples growth and metastasis.
Karras P; Bordeu I; Pozniak J; Nowosad A; Pazzi C; Van Raemdonck N; Landeloos E; Van Herck Y; Pedri D; Bervoets G; Makhzami S; Khoo JH; Pavie B; Lamote J; Marin-Bejar O; Dewaele M; Liang H; Zhang X; Hua Y; Wouters J; Browaeys R; Bergers G; Saeys Y; Bosisio F; van den Oord J; Lambrechts D; Rustgi AK; Bechter O; Blanpain C; Simons BD; Rambow F; Marine JC
Nature; 2022 Oct; 610(7930):190-198. PubMed ID: 36131018
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress inhibits distant metastasis by human melanoma cells.
Piskounova E; Agathocleous M; Murphy MM; Hu Z; Huddlestun SE; Zhao Z; Leitch AM; Johnson TM; DeBerardinis RJ; Morrison SJ
Nature; 2015 Nov; 527(7577):186-91. PubMed ID: 26466563
[TBL] [Abstract][Full Text] [Related]
4. HDAC9/p300/F-actin immunoexpression and migration analysis for malignant melanoma stem cell.
Ozdemir M; Ozdil B; Abdikan CSA; Erisik D; Yesin TK; Avci CB; Kurkutçu Y; Guler G; Aktug H
Pathol Res Pract; 2023 Oct; 250():154829. PubMed ID: 37748211
[TBL] [Abstract][Full Text] [Related]
5. Different growth and metastatic phenotypes associated with a cell-intrinsic change of Met in metastatic melanoma.
Adachi E; Sakai K; Nishiuchi T; Imamura R; Sato H; Matsumoto K
Oncotarget; 2016 Oct; 7(43):70779-70793. PubMed ID: 27683122
[TBL] [Abstract][Full Text] [Related]
6. Transient receptor potential cation 3 channel regulates melanoma proliferation and migration.
Oda K; Umemura M; Nakakaji R; Tanaka R; Sato I; Nagasako A; Oyamada C; Baljinnyam E; Katsumata M; Xie LH; Narikawa M; Yamaguchi Y; Akimoto T; Ohtake M; Fujita T; Yokoyama U; Iwatsubo K; Aihara M; Ishikawa Y
J Physiol Sci; 2017 Jul; 67(4):497-505. PubMed ID: 27613608
[TBL] [Abstract][Full Text] [Related]
7. Transforming Growth Factor-β/Smad Signaling Inhibits Melanoma Cancer Stem Cell Self-Renewal, Tumor Formation and Metastasis.
Boudreault J; Wang N; Ghozlan M; Lebrun JJ
Cancers (Basel); 2024 Jan; 16(1):. PubMed ID: 38201651
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells: a target for overcoming therapeutic resistance and relapse.
Zhang S; Yang R; Ouyang Y; Shen Y; Hu L; Xu C
Cancer Biol Med; 2023 Dec; 20(12):985-1020. PubMed ID: 38164743
[TBL] [Abstract][Full Text] [Related]
9. Heme Oxygenase-1 Has a Greater Effect on Melanoma Stem Cell Properties Than the Expression of Melanoma-Initiating Cell Markers.
Kusienicka A; Bukowska-Strakova K; Cieśla M; Nowak WN; Bronisz-Budzyńska I; Seretny A; Żukowska M; Jeż M; Krutyhołowa R; Taha H; Kachamakova-Trojanowska N; Waś H; Kieda C; Józkowicz A
Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408953
[TBL] [Abstract][Full Text] [Related]
10. Oral Cancer Stem Cells: Therapeutic Implications and Challenges.
Shahoumi LA
Front Oral Health; 2021; 2():685236. PubMed ID: 35048028
[TBL] [Abstract][Full Text] [Related]
11. Cervical cancer stem cell-associated genes: Prognostic implications in cervical cancer.
Organista-Nava J; Gómez-Gómez Y; Garibay-Cerdenares OL; Leyva-Vázquez MA; Illades-Aguiar B
Oncol Lett; 2019 Jul; 18(1):7-14. PubMed ID: 31289465
[TBL] [Abstract][Full Text] [Related]
12. Enrichment and characterization of cancer stem-like cells in ultra-low concentration of serum and non-adhesive culture system.
Zhang J; Zhang Y; Cheng L; Li C; Dai L; Zhang H; Yan F; Shi H; Dong G; Ning Z; Xu W; Si C; Deng H; Xiong H
Am J Transl Res; 2018; 10(5):1552-1561. PubMed ID: 29887968
[TBL] [Abstract][Full Text] [Related]
13. Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells.
Bozorg-Ghalati F; Hedayati M; Dianatpour M; Azizi F; Mosaffa N; Mehrabani D
Asian Pac J Cancer Prev; 2017 Aug; 18(8):2287-2291. PubMed ID: 28843268
[TBL] [Abstract][Full Text] [Related]
14. Do Cancer Cell Lines Have Fixed or Fluctuating Stem Cell Phenotypes? - Studies with the NTera2 Cell Line.
Sellers ZP; Schneider G; Bujko K; Suszynska M; Pedziwiatr D
Stem Cell Rev Rep; 2017 Oct; 13(5):603-610. PubMed ID: 28624968
[TBL] [Abstract][Full Text] [Related]
15. Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations.
Grasso C; Anaka M; Hofmann O; Sompallae R; Broadley K; Hide W; Berridge MV; Cebon J; Behren A; McConnell MJ
BMC Cancer; 2016 Sep; 16(1):726. PubMed ID: 27613604
[TBL] [Abstract][Full Text] [Related]
16. A rational approach for cancer stem-like cell isolation and characterization using CD44 and prominin-1(CD133) as selection markers.
Lee YJ; Wu CC; Li JW; Ou CC; Hsu SC; Tseng HH; Kao MC; Liu JY
Oncotarget; 2016 Nov; 7(48):78499-78515. PubMed ID: 27655682
[TBL] [Abstract][Full Text] [Related]
17. Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo.
Zimmerer RM; Matthiesen P; Kreher F; Kampmann A; Spalthoff S; Jehn P; Bittermann G; Gellrich NC; Tavassol F
Microvasc Res; 2016 Mar; 104():46-54. PubMed ID: 26656667
[TBL] [Abstract][Full Text] [Related]
18. Suitability of CD133 as a Marker for Cancer Stem Cells in Melanoma.
Korn P; Kampmann A; Spalthoff S; Jehn P; Tavassol F; Lentge F; Gellrich NC; Zimmerer R
Asian Pac J Cancer Prev; 2021 May; 22(5):1591-1597. PubMed ID: 34048190
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
